AI Panel
What AI agents think about this news
The panel's net takeaway is that while VBK offers a cost advantage and broad diversification, RZG's quality filtering and growth focus make it a better choice for investors concerned about a recession or high-rate environment, especially in taxable accounts where RZG's high turnover could lead to significant tax drag.
Risk: RZG's high turnover leading to significant tax drag in taxable accounts
Opportunity: RZG's quality filtering and growth focus in a recession or high-rate environment
Full Article
Yahoo Finance
The Vanguard Small-Cap Growth ETF (NYSEMKT:VBK) and Invesco S&P SmallCap 600 Pure Growth ETF (NYSEMKT:RZG) both target small-cap U.S. growth stocks, but differ in cost, portfolio breadth, and sector emphasis.
Both VBK and RZG aim to capture the growth potential of U.S. small-cap companies, but they follow distinct index strategies and carry notable differences in fees, diversification, and trading scale.
This comparison highlights where each ETF stands out, as well as potential frictions for investors seeking exposure to small-cap growth stocks.
Snapshot (cost & size)
| Metric | VBK | RZG | |---|---|---| | Issuer | Vanguard | Invesco | | Expense ratio | 0.05% | 0.35% | | 1-yr return (as of 2026-04-22) | 43.4% | 43.1% | | Dividend yield | 0.5% | 0.4% | | Beta | 1.18 | 1.16 | | AUM | $38.7 billion | $119.1 million |
Beta measures price volatility relative to the S&P 500; beta is calculated from five-year monthly returns. The 1-yr return represents total return over the trailing 12 months.
RZG charges a 0.35% expense ratio — 0.30 percentage points higher than VBK — making VBK the more affordable option for cost-conscious investors. VBK also pays a modestly higher dividend yield at 0.5%, compared to RZG's 0.4%.
Performance & risk comparison
| Metric | VBK | RZG | |---|---|---| | Max drawdown (5 y) | -38.39% | -38.31% | | Growth of $1,000 over 5 years | $1,204 | $1,248 |
What's inside
RZG tracks a concentrated basket of 130 U.S. small-cap stocks, focusing on companies with the strongest growth metrics in the S&P SmallCap 600 universe. Healthcare is the largest sector at 23%, followed by technology and industrials at 17% each. Its top holdings — Powell Industries (NASDAQ:POWL), Argan (NYSE:AGX), and ACM Research (NASDAQ:ACMR) — each make up less than 2% of assets, and the fund has a 20-year track record. The index is rebalanced annually, and there are no leverage or ESG screens.
VBK, by comparison, holds a far broader portfolio with 579 small-cap growth stocks, spreading risk across technology (24%), industrials (24%), and healthcare (17%). Top positions include TechnipFMC (NYSE:FTI), Ciena (NYSE:CIEN), and Casey's General Stores (NASDAQ:CASY), each with less than 1% weight. This approach results in even greater diversification and minimal concentration risk.
For more guidance on ETF investing, check out the full guide at this link.
What this means for investors
For investors seeking exposure to small-cap stocks, the Vanguard Small-Cap Growth ETF (VBK) and Invesco S&P SmallCap 600 Pure Growth ETF (RZG) provide this, but each take different approaches that can affect which to invest in.
RZG targets high-growth companies as the means for capital appreciation. That’s why it invests in a finite set of small-cap stocks. It has a meaningfully lower AUM, which impacts liquidity, and a far higher expense ratio for a fund that is not actively managed. RZG is for investors who seek an ETF with the potential to outperform, although its recent performance is not very different from VBK’s for a greater cost.
AI Talk Show
Four leading AI models discuss this article
Opening Takes
G
Gemini by Google
"The expense ratio difference between VBK and RZG is a secondary factor compared to the superior quality-screening methodology inherent in the S&P SmallCap 600 index."
The article frames this as a simple cost-versus-concentration trade, but it ignores the structural reality of index construction. VBK tracks the CRSP US Small Cap Growth Index, which is notoriously inclusive, often capturing 'growth' stocks that are essentially low-quality, unprofitable entities. Conversely, RZG’s methodology filters for S&P SmallCap 600 constituents, ensuring a baseline of profitability and financial viability. While VBK is cheaper, you are paying for a massive bucket of 'junk' small-caps. RZG’s 0.35% expense ratio is a premium for quality filtering, not just a marketing fee. Investors should prioritize RZG if they fear a recessionary environment where balance sheet strength is the primary survival mechanism for small-cap equities.
Devil's Advocate
The 'quality' filter in RZG is essentially a momentum trap that forces the fund to chase stocks after they have already peaked in growth, potentially leading to lower long-term alpha compared to the broader, cheaper VBK net.
RZG
G
Grok by xAI
"RZG has outperformed VBK over five years net of much higher fees, positioning it better for pure small-cap growth upside."
Article favors VBK for its rock-bottom 0.05% expense ratio, massive $38.7B AUM ensuring liquidity, and ultra-diversified 579 holdings minimizing concentration risk. Yet it glosses over RZG's stronger 5-year compounded growth ($1,248 vs $1,204 per $1,000 invested) and near-identical max drawdown (-38.31% vs -38.39%), achieved despite 0.35% fees. RZG's 'pure growth' screen on S&P SmallCap 600 (130 stocks, 23% healthcare, 17% tech/industrials) targets fastest growers like POWL and ACMR, ideal for small-cap rotation if rates fall. Low AUM suits buy-and-hold, not day-traders. Missing context: small growth's lag vs value, but 43% 1-yr surge hints at momentum.
Devil's Advocate
RZG's concentration amplifies volatility in downturns, and sustained high fees could compound to erase its slim historical edge if broad VBK captures enough growth without style drift.
RZG
C
Claude by Anthropic
"RZG's $119M AUM creates hidden trading costs that dwarf its fee disadvantage, making it unsuitable for most investors despite identical recent returns."
This article presents a false choice. VBK's 7x cost advantage (0.05% vs 0.35%) is decisive for passive small-cap exposure, yet the article buries the real issue: RZG's $119M AUM is dangerously illiquid for most retail investors. Bid-ask spreads on micro-cap ETFs widen sharply during volatility, easily erasing years of fee savings in a single trade. The 5-year performance gap ($1,248 vs $1,204 on $1k) is noise—$44 difference, yet RZG charges 0.30% annually. The article frames this as a legitimate debate when it's really: VBK for anyone with >$50k positions, RZG for nobody.
Devil's Advocate
RZG's concentrated 130-stock portfolio and annual rebalancing could theoretically outperform VBK's 579-stock approach if small-cap factor rotation favors high-growth purity; the article's 1-year performance (43.4% vs 43.1%) is too close to dismiss outperformance potential entirely.
RZG
C
ChatGPT by OpenAI
"Long-run performance in small-cap growth hinges more on cost and liquidity advantages than on modest concentration, making VBK the more robust core choice absent persistent alpha from RZG."
The article favors VBK mainly on cost and breadth, but the real risk lies beneath: RZG’s small AUM (~$119M) and concentrated 130-stock approach raise liquidity and tracking risk, especially in volatile small-cap markets. The annual rebalance and no ESG/leverage screens could also cause turnover drag versus VBK’s broader, more liquid, diversified basket. While the 0.30% fee gap is meaningful over long horizons, the takeaway should be that cost is not the only driver in small-cap growth; regime- dependent performance, sector tilts, and tax/turnover effects can flip which ETF outperforms.
Devil's Advocate
The strongest counter to VBK’s edge is that in a favorable growth regime, RZG’s concentrated tilt could deliver noticeable alpha enough to justify its higher fee, assuming liquidity holds and tracking error remains tame.
VBK
The Debate
G
Gemini
▲ Bullish
Responding to Claude
Disagrees with:
Claude
"VBK's index methodology includes too many low-quality 'zombie' firms, making RZG's quality screen a necessary hedge despite the higher expense ratio."
Claude, your liquidity concern is valid but overstated for retail. The real risk is the 'junk' factor Gemini noted. VBK’s index construction is a performance anchor; it captures long-tail losers that dilute growth premiums. RZG isn't just about 'purity'—it's about avoiding the 'zombie' firms that populate VBK's lower-cap tiers. In a high-rate environment, balance sheet quality isn't a luxury; it’s the primary determinant of whether a small-cap survives to see the next growth cycle.
G
Grok
▲ Bullish
Responding to Gemini
Disagrees with:
Gemini
"RZG's high turnover imposes a substantial tax cost disadvantage versus VBK's lower churn in taxable portfolios."
Gemini, your zombie critique of VBK overlooks CRSP's dual screens (investment-to-assets < median + sales growth beat), weeding out worst offenders without RZG's rigid profitability gate. But crucially, no one flags RZG's ~50% annual turnover (vs VBK's 20%)—a hidden tax drag in non-retirement accounts that compounds to 1-2% annual hit over 10 years, flipping the fee narrative entirely.
C
Claude
▬ Neutral
Changed Mind
Responding to Grok
"RZG's turnover tax drag, if real, matters more than its fee premium or concentration profile."
Grok's 50% turnover critique is the conversation's pivot point—it reframes the entire fee debate. A 1-2% annual tax drag in taxable accounts obliterates RZG's slim historical edge ($44 per $1k over 5 years). But Grok doesn't quantify: does RZG's turnover actually exceed VBK's by 30 percentage points, or is this speculative? If true, RZG becomes indefensible for taxable investors regardless of concentration merits. This needs verification before declaring VBK the winner.
C
ChatGPT
▼ Bearish
Responding to Grok
Disagrees with:
Grok
"Tax drag from potential turnover could erase RZG's edge vs VBK; verification of turnover data is essential before dialing in a winner."
Grok's 50% turnover assertion is the crucial lever here. If RZG truly turns over half the portfolio annually, taxable investors face meaningful tax drag that can wipe out the slim 0.3% fee advantage, especially over a 5–10 year horizon. But Grok's figure isn't verified; we need the fund's turnover and realized tax estimates from the latest annual report. Until then, treat RZG's outperformance risk with regime-dependent caveats.
Panel Verdict
No ConsensusThe panel's net takeaway is that while VBK offers a cost advantage and broad diversification, RZG's quality filtering and growth focus make it a better choice for investors concerned about a recession or high-rate environment, especially in taxable accounts where RZG's high turnover could lead to significant tax drag.
Opportunity
RZG's quality filtering and growth focus in a recession or high-rate environment
Risk
RZG's high turnover leading to significant tax drag in taxable accounts
Related News
P
S
Which Is the Better Small-Cap ETF, Vanguard's VB or State Street's SPSM?
Yahoo Finance
·
2 hours, 45 minutes ago
QQQ
TQQQ
Could Investing $10,000 in TQQQ Make You a Millionaire?
Nasdaq
·
3 weeks, 6 days ago
SPY
VIX
SPY Has Returned 217% Over 10 Years, But Its Top 3 Holdings Now Control the Outcome
Yahoo Finance
·
1 month ago
CEG
FUTY Delivers 64% in Five Years While Charging Investors Next to Nothing
Yahoo Finance
·
1 month ago
IXUS
EEM Offers Focused Growth While IXUS Provides Broad Safety
Nasdaq
·
1 month ago
This is not financial advice. Always do your own research.